Fialuridine i-124

Iodine I-124 FIAU is a radioconjugate containing the nucleoside analog 2′-fluoro-2′-deoxy-1beta-D-arabinofuranosyl-5-iodouracil (FIAU) labeled with the radioisotope iodine I 124 with positron-emitting activity. Chemotherapeutic agents including bortezomib may induce viral thymidine kinase expression in EBV- and Kaposi’s sarcoma herpesvirus (KSHV)-associated tumors. Subsequent to chemotherapy induction of viral TK in these tumors, administered iodine I 124 FIAU is phosphorylated by expressed viral TK, becoming selectively trapped within TK-expressing tumor cells; these cells can then be visualized with positron emission tomography (PET). Viral TK is either not expressed or is expressed at very low levels in EBV- and Kaposi’s sarcoma herpesvirus (KSHV)-associated tumors and may be activated by certain chemotherapeutic agents. Its therapeutic use is listed as diagnostic agents. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include 124I-Labeled FIAU and 124I-FIAU. Its PubChem CID is 656409.

CAS No 183293-72-3
Molecular Formula C9H10FIN2O5
Molecular Weight 369.09 g/mol
Synonyms 1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(124I)iodopyrimidine-2,4-dione

Frequently Asked Questions